Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-014896
Filing Date
2023-04-26
Accepted
2023-04-26 17:20:20
Documents
71
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nvro-20230331.htm   iXBRL 10-Q 2227091
2 EX-31.1 nvro-ex31_1.htm EX-31 16725
3 EX-31.2 nvro-ex31_2.htm EX-31 16743
4 EX-32.1 nvro-ex32_1.htm EX-32 10293
  Complete submission text file 0000950170-23-014896.txt   8437578

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvro-20230331.xsd EX-101.SCH 46722
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nvro-20230331_cal.xml EX-101.CAL 57407
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvro-20230331_lab.xml EX-101.LAB 406393
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvro-20230331_pre.xml EX-101.PRE 293998
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nvro-20230331_def.xml EX-101.DEF 145007
65 EXTRACTED XBRL INSTANCE DOCUMENT nvro-20230331_htm.xml XML 1745607
Mailing Address 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065 650-251-0005
NEVRO CORP (Filer) CIK: 0001444380 (see all company filings)

EIN.: 562568057 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36715 | Film No.: 23850869
SIC: 3841 Surgical & Medical Instruments & Apparatus